Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Burkitt Lymphoma 20Multiple Myeloma 16Lymphoma, Large B-Cell, Diffuse 15Leukemia, Myeloid, Acute 14Lymphoma, Non-Hodgkin 13Lymphoma, Follicular 13Lymphoma, B-Cell 12Lymphoma 12Recurrence 10Myelodysplastic Syndromes 10Leukemia, Lymphocytic, Chronic, B-Cell 10Ovarian Neoplasms 9Hematologic Neoplasms 9Lymphoma, Mantle-Cell 8Hodgkin Disease 8Pancreatic Neoplasms 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myelomonocytic, Chronic 6Breast Neoplasms 6Neoplasms 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Biphenotypic, Acute 5Triple Negative Breast Neoplasms 4Stomach Neoplasms 4Sarcoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Osteosarcoma 4

Interventions

Specimen Handling 5Biopsy 5X-Rays 4Phantoms, Imaging 4Nuclear Medicine Department, Hospital 4Magnetic Resonance Spectroscopy 4larotrectinib 2erdafitinib 2ensartinib 2ulixertinib 1tipifarnib 1tazemetostat 1selpercatinib 1palbociclib 1olaparib 1niraparib 1ivosidenib 1elacestrant 1cabozantinib 1alectinib 1abemaciclib 1Vincristine 1Vinblastine 1Vemurafenib 1Topotecan 1Temozolomide 1RAD1901 1Nivolumab 1Methotrexate 1LY3023414 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Central Nervous System Neoplasms × Cyclophosphamide × 30 days × Clear all
NCT00602667 2026-05-19

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
293 enrolled 89 charts
CNS

Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡